Heart Failure
Devices and Surgical Techniques Learning Series
Devices for Chronic HF
Advertisement
Episodes
Eliminating the Driveline: The Ultimate Solution
15 min.
Getting in Sync With CorWave
7 min.
Syncardia Total Artificial Heart: Current Outcomes as a Foundation for a New, Fully Implantable Total Artificial Heart
6 min.
The Future of BiV Failure: BiVACOR
7 min.
TORVAD: A Toroidal, Pulsatile Flow LVAD
7 min.
Case Presentation: Decompensated BiV Failure PT
3 min.
Debate: Patients Should Go Directly for an LVAD
6 min.
Recovery From Advance HF: Candidate Selection, Durability and Magnitude of Opportunity
13 min.
DOACS in LVAD: Should We, Should We Not?
10 min.
Treating Aortic Regurgitation in LVAD Patients - Who, When and How
11 min.
Remote Monitoring in LVAD Patients
9 min.
Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD
18 min.
When to Use a Form of Replacement Therapies
7 min.
Congestion in Heart Failure: How Aggressive Should We Be to Dry Patients Out
8 min.
When and Why Are Diuretics Sometimes Just Not Enough?
8 min.
Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis
13 min.
When to Use Devices the Recude Renal Vein Pressure
6 min.
When to Use a Noninvasive Device That Remove Fluid From the Extracellular Space
7 min.
When to Use an Invasive Device That Removes Fluid From the Extracellular Space
9 min.
A Device Designed for Patient Comfort - BrioVAD
8 min.
My Most Important Lessons Learned from Elective and Emergent Left Ventricle Repair and Intervention
15 min.
Controlled Pulmonary Banding for Dilated Cardiomyopathy: RESTORE Medical Clinical Results
9 min.
Current Treatment Options for HFrEF Patients Failing GDMT
8 min.
Treating the Dilated LV from Inside the LV Chamber: The ACCUCINCH System and CORCINCH-HF Pivotal Study
6 min.
Intramyocardial Cinching of the Dilated LV: The MIRTH Approach
4 min.
Cinching the Dilated LV From the Coronary Sinus Using the CARILLON Device
4 min.
Remodeling the LV by Approximating the Bases of the Papillary Muscles: The V-SLING Concept
5 min.
Anterior Scar Exclusion Using the BioVentrix REVIVANT System
5 min.
Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics
10 min.
Structural Remodeling of the Failing LV: Concepts and Devices
15 min.
Interatrial Shunts: Devices, Clinical Results, and Future Prospects
14 min.
Transcatheter Pulmonary Artery Banding In Chronic Heart Failure [HFrEF]: Results From the First-in-Human Study
8 min.
Pre-Clinical Results With A Chronically-Adjustable And Pressure Sensing Interatrial Shunt (Adona Medical)
11 min.
MIRTH Ventriculoplasty (Myocardial Intramural Remodeling by Endovenous TeTHer)
12 min.
Ventricular Unloading and Reverse Remodeling in Heart Failure
26 min.
Transcatheter Pulmonary Artery Banding in Chronic Heart Failure: Results From an Early Feasibility Study
11 min.
Long-term Outcomes of Endovascular Baroreflex Amplification in Symptomatic Patients With HFrEF
11 min.
The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients
11 min.
Physiological Modeling at Rest and Exercise of a Novel Right-to-Right Cardiac Shunt
15 min.
Clinical Feasibility of a Novel Right-to-Right Cardiac Shunt in Pulmonary Hypertension using Off-the-Shelf Devices
12 min.
No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Six-Month Outcomes From Multi-Center Pilot Feasibility Studies
12 min.
Harnessing the Lymphatic System the Treat Heart Failure
23 min.
Novel Imaging Methods and Interventions of the Lymphatic System
13 min.
The Lymphatic System and The Role in Heart Failure
13 min.
Shunt Devices in Pulmonary Hypertension Management
10 min.
Splanchnic Nerve Denervation for HFrEF and HFpEF
8 min.
Cardiac Contractility Modulation for HFrEF and HFpEF: Impulse Dynamics
9 min.
Mechanical Stimulation of the Carotid Sinus: MobiusHD
5 min.
Aortic Arch Simulation (Enopace)
8 min.
Vagal Nerve Stimulation (ANTHEM)
8 min.
Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes
9 min.
Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients
14 min.
Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial
10 min.
Impact of the V-Wave® Ventura® Interatrial Shunt Device on Right and Left Ventricular Structure and Function: Complete 12-Month Results of the RELIEVE-HF Roll-in Cohort
10 min.
IFPx - A Minimally-Invasive Multiparameter Remote Heart Failure Sensor With Integrated Interstitial Pressure Measurement
13 min.
Syntach Cardiac Support System - Minimally Invasive Fully Implantable Cardiac Support Technology To Restore Cardiac Function In Heart Failure Patients
14 min.
Acorai Save Sensor - A Novel Non-Invasive Multi-Sensor Medical Device For Measurement And Estimation Of Absolute Intracardiac Pressure, Enabling Early Detection And Ongoing Management Of Heart Failure Patients And Pulmonary Hypertension
11 min.
Corstasis - Intranasal Diuretic for the Treatment of CHF Refractory to Oral Diuretics.
15 min.
THT Shark Tank Winner Announcement
3 min.
Device-Based LV Remodeling as a Therapy for HFrEF: MIRTH - Myocardial Intramural Remodeling by Transvenous Tether
6 min.
Device-Based LV Remodeling as a Therapy for HFrEF: CardiacSuccess / V-Sling
5 min.
Device-Based LV Remodeling as a Therapy for HFrEF: CardiacDimensions
7 min.
Device-Based LV Remodeling as a Therapy for HFrEF: Bioventrix
7 min.
Device-Based LV Remodeling as a Therapy for HFrEF: Ancora
7 min.
Biological vs Physical Reverse Remodeling in Heart Failure: Implications for Device-Based Therapies for HFrEF
10 min.
Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Design for Trials on Chronic Heart Failure Devices
10 min.
Regulatory Aspects for Chronic Heart Failure Devices - FDA Perspective
10 min.
Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial
10 min.
Interatrial Shunts for the Treatment of Heart Failure: InterShunt - Cut, Capture and Leave Nothing Behind
8 min.
Interatrial Shunts for the Treatment of Heart Failure: The Occlutech AFR - Matching Shunt Length and Diameter to the Patient
7 min.
Interatrial Shunts for the Treatment of Heart Failure: V-Wave - Different Shape, Different Effect?
6 min.
Interatrial Shunts for the Treatment of Heart Failure: LA to Coronary Sinus - The Edwards APTURE Shunt
4 min.
Interventional Therapies for HFpEF
9 min.
Does this patient have HFpEF and if so how to treat? - Mystery Case 1
14 min.
Does this patient have HFpEF and if so how to treat? - Mystery Case 2
9 min.
Interatrial Shunts for the Treatment of Heart Failure: What We Know and What We Don't Know
11 min.
Interatrial Shunts for the Treatment of Heart Failure: Implications of Left Atrial Hypertension at Rest and Exercise
8 min.
Interatrial Shunts for the Treatment of Heart Failure: Alleviant - Leave Nothing Behind
6 min.
Assessing the Residual Risk: What Gaps Should New Technologies Fill?
8 min.
Position 2: Hey… What About Creating an Atrial Shunt for Heart Failure
12 min.
The Current Status of Interatrial Shunts for HFrEF and HFpEF (Importance of Hemodynamic Exercise Testing)
11 min.
A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)
7 min.
Myocardial Intramural Remodeling by Endovenous TeTHer (MIRTH)
7 min.
Reshaping the Failing Heart From the Coronary Sinus: The Carillon Device and Pivotal Study
9 min.
Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study
12 min.
Reshaping the Failing Heart From Inside the LV Chamber: The Accucinch Device and Pivotal Study
9 min.
Reshaping the Failing Heart by Tethering the Bases of the Papillary Muscles
7 min.
Overview of Device-Based Therapies for Heart Failure
8 min.
Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)
8 min.